Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by RalphRalph


ATBPF

RE:RE:RE:RE:RE:A new prospectus

From today's prospectus, "Use of Proceeds" section: "The...

July 23, 2019

ATBPF

RE:RE:RE:A new prospectus

The animal toxicology studies, I believe.

July 23, 2019

ATBPF

Question regarding a potential Phase 3

Obviously this is  completely dependent on positive results from this...

July 16, 2019

ATBPF

RE:RE:RE:RE:RE:Naproxen-H2S (ATB-346) vs. Placebo (nothing) = Instant Money

I agree, and that's why I said WOMAC better than or equal to that of...

June 28, 2019

ATBPF

RE:RE:RE:Naproxen-H2S (ATB-346) vs. Placebo (nothing) = Instant Money

mstrmnd wrote: Dose-Ranging: No need to show it's better or even equal...

June 28, 2019

ATBPF

RE:Naproxen-H2S (ATB-346) vs. Placebo (nothing) = Instant Money

I understand your thinking, & know that officially the trial is comparing...

June 28, 2019

ATBPF

RE:RE:RE:RE:RE:RE:RE:MM

Thank you for that data.  Would be great if Citagenix gets going in the...

June 26, 2019

ATBPF

RE:RE:RE:RE:RE:MM

CyrolQue wrote: The CEO letter is indeed simple. Yet, for the shake of the...

June 26, 2019

ATBPF

RE:Competitive landscape

There's been some justifiable concern about the competition listed in the...

November 30, 2018

Prev 1 2 3 4 5